Premium for Development of New Drugs Is Fiscal Neutrality System: Mr Kamoya of JPMA

At a seminar sponsored by the Federation of Japan Pharmaceutical Wholesalers Association (JPWA), Yoshiaki Kamoya, chairman of the Marketing Committee of the Japan Pharmaceutical Manufacturers Association (JPMA) and an expert member at the Central Social Insurance Medical Council (CSIMC; Chuikyo...read more